By Cynthia Belaskie and Lucas Richert
We weren’t left to wait in the B.C. rain. After presenting our IDs at the security station outside Tilray’s medical cannabis facility in Nanaimo, and once we were confirmed as being on the official “list,” it took less than a minute to enter the recently constructed $30 million, 65,000 square-foot facility.
There were four of us taking the tour of Tilray, one of Canada’s licensed producers of medical marijuana. We were part of a SSHRC-funded conference in the history of drugs and alcohol at Vancouver Island University, and this was one of the activities available to us as participants in the event.
Our guide was Philippe Lucas, Vice-President of Patient Services at Tilray. He walked us through the electric gate and led us into a cozy holding room filled with bottles of San Pellegrino, a weigh scale, and a flat screen TV flashing images of the building’s construction. A former city councilor in Victoria, an expert witness on marijuana in Canada, and one-time dispensary owner, Philippe was handsome. He spoke quickly, laughed easily, and possessed an air of mischief, too.
Over the past ten years, Philippe has published peer-reviewed articles on cannabis’s therapeutic effects on patients in top academic journals around the world. Continue reading